ストックスクリーナーアプリを入手
75.05
0.08%
-0.06
アフターアワーズ：
75.01
-0.04
-0.05%
前日終値:
$75.11
開ける：
$75.12
24時間の取引高:
2.02M
Relative Volume:
0.60
時価総額：
$16.74B
収益：
$4.04B
当期純損益:
$557.10M
株価収益率:
31.14
EPS:
2.4102
ネットキャッシュフロー:
$916.70M
1週間 パフォーマンス:
+0.09%
1か月 パフォーマンス:
+0.24%
6か月 パフォーマンス:
+13.80%
1年 パフォーマンス:
+6.15%
1日の値動き範囲:
$75.00
$75.17
1週間の範囲:
$74.86
$75.31
52週間の値動き範囲:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
HOLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.05 | 16.75B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
523.99 | 186.40B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
201.79 | 58.70B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.29 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.00 | 38.25B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.38 | 37.27B | 5.26B | 1.44B | 1.76B | 9.7713 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | ダウングレード | Argus | Buy → Hold |
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-11-21 | ダウングレード | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-08-18 | アップグレード | Argus | Hold → Buy |
| 2025-08-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-05-27 | 繰り返されました | Needham | Hold |
| 2025-03-03 | ダウングレード | Argus | Buy → Hold |
| 2025-02-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | ダウングレード | Needham | Buy → Hold |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-10 | 開始されました | Jefferies | Hold |
| 2024-12-10 | 繰り返されました | Needham | Buy |
| 2024-10-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-27 | 開始されました | Stephens | Overweight |
| 2024-04-03 | アップグレード | Citigroup | Neutral → Buy |
| 2023-07-14 | アップグレード | Needham | Hold → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-07-20 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-07-20 | 開始されました | UBS | Neutral |
| 2022-07-18 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-07-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-11-20 | ダウングレード | Needham | Buy → Hold |
| 2020-11-05 | 繰り返されました | Needham | Buy |
| 2020-06-30 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-06-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 繰り返されました | Needham | Buy |
| 2020-04-30 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 繰り返されました | Needham | Buy |
| 2019-05-02 | 繰り返されました | Needham | Buy |
| 2019-01-31 | 繰り返されました | Needham | Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 開始されました | UBS | Neutral |
| 2018-09-13 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Hologic Inc (HOLX) 最新ニュース
The Truth About Hologic Inc: Why This ‘Boring’ Stock Could Be a Silent Game-Changer - AD HOC NEWS
Hologic Faces Del. Class Suit Over $18.3B Sale Disclosures - Law360
Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica - GlobeNewswire Inc.
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz
Hologic Q1 Earnings Preview: How Should You Play the Stock Now? - Finviz
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? - Finviz
Here's Why Hologic (HOLX) is a Strong Momentum Stock - Yahoo Finance
Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? - The Globe and Mail
(HOLX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Hologic, Inc. (HOLX): A Bear Case Theory - Finviz
Hologic, Inc. (HOLX): A bear case theory - MSN
Aug Shorts: Is Hologic Inc attractive for institutional investors2025 Key Highlights & Advanced Technical Analysis Signals - baoquankhu1.vn
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? - Yahoo Finance
3D Imaging Teleradiology Service Market Hits New High | Major - openPR.com
Is Hologic Inc. stock a buy or sellJuly 2025 Trends & Long-Term Growth Stock Strategies - bollywoodhelpline.com
Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals - Yahoo Finance
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
'Good Morning Gorgeous': Hologic, Mary J. Blige Team To Tout Well Woman Exams 08/22/2022 - MediaPost
How low can spreads go? Hologic’s mega LBO tests the limit - PitchBook
Hologic wraps massive syndicated LBO loan - PitchBook
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - The Globe and Mail
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Sahm
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途资讯
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026Hologic, Inc. - Hologic, Inc. - Investor Relations
About Us - FinancialContent
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening - GuruFocus
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic (NASDAQ:HOLX) Downgraded by Argus to "Hold" - MarketBeat
Blackstone (BX) Involved in Hologic Acquisition Deal - GuruFocus
SG Americas Securities LLC Grows Position in Hologic, Inc. $HOLX - MarketBeat
Is Hologic Inc. stock affected by interest rate hikesPortfolio Update Summary & Daily Risk Controlled Trade Plans - Улправда
(HOLX) Risk Channels and Responsive Allocation - Stock Traders Daily
What market sentiment indicators show for Hologic Inc. (HO1) stock2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Why Hologic Inc. stock is recommended by analystsJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
Hologic issues safety alert for breast biopsy needles - Radiology Business
Why Hologic Inc. stock appeals to analystsInflation Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Hologic Inc (HOLX) 財務データ
収益
当期純利益
現金流量
EPS
4.49%
大文字化:
|
ボリューム (24 時間):